Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s

Background. Antiretroviral therapy (ART) can alter glucose metabolism, but little data exist on the association of raltegravir (RAL) with insulin resistance. Methods. A5260s was a substudy of A5257, a prospective open-label randomized trial in which human immunodeficiency virus (HIV)-infected treatm...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: Dirajlal-Fargo, Sahera, Moser, Carlee, Brown, Todd T., Kelesidis, Theodoros, Dube, Michael P., Stein, James H., Currier, Judith, McComsey, Grace A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Major Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5047417/
https://ncbi.nlm.nih.gov/pubmed/27704026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw174
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia